Next Science Statistics

Total Valuation

Next Science has a market cap or net worth of AUD 23.96 million. The enterprise value is 25.28 million.

Market Cap	23.96M
Enterprise Value	25.28M

Important Dates

The next estimated earnings date is Friday, July 25, 2025.

Earnings Date	Jul 25, 2025
Ex-Dividend Date	n/a

Share Statistics

Next Science has 292.16 million shares outstanding. The number of shares has increased by 24.69% in one year.

Current Share Class	292.16M
Shares Outstanding	292.16M
Shares Change (YoY)	+24.69%
Shares Change (QoQ)	+0.14%
Owned by Insiders (%)	31.22%
Owned by Institutions (%)	7.06%
Float	139.47M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.65
PB Ratio	4.31
P/TBV Ratio	5.67
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.48
EV / Sales	0.69
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.95

Financial Position

The company has a current ratio of 1.88, with a Debt / Equity ratio of 0.72.

Current Ratio	1.88
Quick Ratio	1.56
Debt / Equity	0.72
Debt / EBITDA	n/a
Debt / FCF	-0.31
Interest Coverage	-47.28

Financial Efficiency

Return on equity (ROE) is -130.18% and return on invested capital (ROIC) is -64.79%.

Return on Equity (ROE)	-130.18%
Return on Assets (ROA)	-47.12%
Return on Invested Capital (ROIC)	-64.79%
Return on Capital Employed (ROCE)	-170.48%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.68
Inventory Turnover	6.04

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -73.55% in the last 52 weeks. The beta is 1.31, so Next Science's price volatility has been higher than the market average.

Beta (5Y)	1.31
52-Week Price Change	-73.55%
50-Day Moving Average	0.10
200-Day Moving Average	0.14
Relative Strength Index (RSI)	31.63
Average Volume (20 Days)	93,317

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Next Science had revenue of AUD 36.87 million and -17.11 million in losses. Loss per share was -0.06.

Revenue	36.87M
Gross Profit	29.80M
Operating Income	-16.52M
Pretax Income	-17.11M
Net Income	-17.11M
EBITDA	-15.74M
EBIT	-16.52M
Loss Per Share	-0.06

Full Income Statement

Balance Sheet

The company has 2.70 million in cash and 4.03 million in debt, giving a net cash position of -1.32 million or -0.00 per share.

Cash & Cash Equivalents	2.70M
Total Debt	4.03M
Net Cash	-1.32M
Net Cash Per Share	-0.00
Equity (Book Value)	5.56M
Book Value Per Share	0.02
Working Capital	4.58M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -12.87 million and capital expenditures -74,848, giving a free cash flow of -12.94 million.

Operating Cash Flow	-12.87M
Capital Expenditures	-74,848
Free Cash Flow	-12.94M
FCF Per Share	-0.04

Full Cash Flow Statement

Margins

Gross margin is 80.83%, with operating and profit margins of -44.80% and -46.40%.

Gross Margin	80.83%
Operating Margin	-44.80%
Pretax Margin	-46.40%
Profit Margin	-46.40%
EBITDA Margin	-42.70%
EBIT Margin	-44.80%
FCF Margin	n/a

Dividends & Yields

Next Science does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.69%
Shareholder Yield	n/a
Earnings Yield	-71.40%
FCF Yield	-54.03%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Next Science has an Altman Z-Score of -9.15. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-9.15
Piotroski F-Score	n/a